Kissei Pharmaceutical Co Ltd
TSE:4547

Watchlist Manager
Kissei Pharmaceutical Co Ltd Logo
Kissei Pharmaceutical Co Ltd
TSE:4547
Watchlist
Price: 3 655 JPY -0.95% Market Closed
Market Cap: 161.6B JPY
Have any thoughts about
Kissei Pharmaceutical Co Ltd?
Write Note

Relative Value

The Relative Value of one Kissei Pharmaceutical Co Ltd stock under the Base Case scenario is 3 080.36 JPY. Compared to the current market price of 3 655 JPY, Kissei Pharmaceutical Co Ltd is Overvalued by 16%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
3 080.36 JPY
Overvaluation 16%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
19
vs Industry
54
Median 3Y
1.8
Median 5Y
1.8
Industry
2.5
Forward
1.9
vs History
44
vs Industry
33
Median 3Y
12.1
Median 5Y
14.2
Industry
21.9
Forward
13.3
vs History
20
vs Industry
Median 3Y
-25.9
Median 5Y
-23.5
Industry
16.5
vs History
1
vs Industry
Median 3Y
-24.6
Median 5Y
-23
Industry
23.6
vs History
9
vs Industry
71
Median 3Y
0.6
Median 5Y
0.6
Industry
2.1
vs History
15
vs Industry
65
Median 3Y
1.2
Median 5Y
1
Industry
2.6
Forward
1.3
vs History
19
vs Industry
64
Median 3Y
2.5
Median 5Y
2
Industry
5.2
vs History
60
vs Industry
31
Median 3Y
19.4
Median 5Y
14.9
Industry
13.3
Forward
9.1
vs History
38
vs Industry
18
Median 3Y
-29
Median 5Y
23.8
Industry
16.6
Forward
0
vs History
20
vs Industry
Median 3Y
-18.6
Median 5Y
-16.3
Industry
15.6
vs History
1
vs Industry
Median 3Y
-15.8
Median 5Y
-14.1
Industry
19.1
vs History
12
vs Industry
75
Median 3Y
0.5
Median 5Y
0.4
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Kissei Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Kissei Pharmaceutical Co Ltd
TSE:4547
161.6B JPY 2 15.1 13.6 29.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
JP
Kissei Pharmaceutical Co Ltd
TSE:4547
Average P/E: 30.2
15.1
-27%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top